Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1586

1.

Clinical and Bacterial Risk Factors for Development of Post-Prostate Biopsy Infections.

Hasanzadeh A, Black P, Pourmand MR, Pourmand G.

Urol J. 2019 Mar 18. doi: 10.22037/uj.v0i0.4603. [Epub ahead of print]

2.

New horizons in bladder cancer research.

Boormans JL, Zwarthoff EC, Black PC, Goebell PJ, Kamat AM, Nawroth R, Seiler R, Williams SB, Schmitz-Dräger BJ.

Urol Oncol. 2019 Mar 7. pii: S1078-1439(18)30508-8. doi: 10.1016/j.urolonc.2018.12.014. [Epub ahead of print] Review.

PMID:
30852032
3.

Comparison of Artificial Intelligence Techniques to Evaluate Performance of a Classifier for Automatic Grading of Prostate Cancer From Digitized Histopathologic Images.

Nir G, Karimi D, Goldenberg SL, Fazli L, Skinnider BF, Tavassoli P, Turbin D, Villamil CF, Wang G, Thompson DJS, Black PC, Salcudean SE.

JAMA Netw Open. 2019 Mar 1;2(3):e190442. doi: 10.1001/jamanetworkopen.2019.0442.

PMID:
30848813
4.

Canadian Urological Association guideline: Muscle-invasive bladder cancer.

Kulkarni GS, Black PC, Sridhar SS, Kapoor A, Zlotta AR, Shayegan B, Rendon R, Chung P, Van Der Kwast T, Alimohamed N, Fradet Y, Kassouf W.

Can Urol Assoc J. 2019 Jan 31. doi: 10.5489/cuaj.5902. [Epub ahead of print] No abstract available.

PMID:
30763236
5.

Predictive Biomarkers for Checkpoint Blockade in Urothelial Cancer: A Systematic Review.

Lavoie JM, Black PC, Eigl BJ.

J Urol. 2019 Feb 4. doi: 10.1097/JU.0000000000000136. [Epub ahead of print]

PMID:
30730407
6.

Wearable technology-based metrics for predicting operator performance during cardiac catheterisation.

Currie J, Bond RR, McCullagh P, Black P, Finlay DD, Gallagher S, Kearney P, Peace A, Stoyanov D, Bicknell CD, Leslie S, Gallagher AG.

Int J Comput Assist Radiol Surg. 2019 Apr;14(4):645-657. doi: 10.1007/s11548-019-01918-0. Epub 2019 Feb 7.

PMID:
30730031
7.

Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer.

Efstathiou JA, Mouw KW, Gibb EA, Liu Y, Wu CL, Drumm MR, da Costa JB, du Plessis M, Wang NQ, Davicioni E, Feng FY, Seiler R, Black PC, Shipley WU, Miyamoto DT.

Eur Urol. 2019 Feb 1. pii: S0302-2838(19)30012-0. doi: 10.1016/j.eururo.2019.01.011. [Epub ahead of print]

PMID:
30712971
8.

Editorial: Basic research in bladder cancer - refining the tools. 3rd IBCN seminars series1.

Black PC, Goebell PJ, Kamat AM, Nawroth R, Seiler R, Williams SB, Schmitz-Dräger BJ.

Urol Oncol. 2019 Jan 22. pii: S1078-1439(19)30003-1. doi: 10.1016/j.urolonc.2019.01.003. [Epub ahead of print] Review.

PMID:
30683454
9.

Global, Regional, and National Burden of Bladder Cancer, 1990 - 2016: Results from the Global Burden of Disease Study 2016.

Ebrahimi H, Amini E, Pishgar F, Moghaddam SS, Nabavizadeh B, Rostamabadi Y, Aminorroaya A, Fitzmaurice C, Farzadfar F, Nowroozi MR, Black PC, Daneshmand S.

J Urol. 2019 Jan 25. doi: 10.1097/JU.0000000000000025. [Epub ahead of print]

PMID:
30676477
10.

SIU-ICUD consultation on bladder cancer 2018.

Black P, Gontero P.

World J Urol. 2019 Jan;37(1):1-2. doi: 10.1007/s00345-018-2601-3. No abstract available.

PMID:
30666399
11.

Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer.

Vandekerkhove G, Struss WJ, Annala M, Kallio HML, Khalaf D, Warner EW, Herberts C, Ritch E, Beja K, Loktionova Y, Hurtado-Coll A, Fazli L, So A, Black PC, Nykter M, Tammela T, Chi KN, Gleave ME, Wyatt AW.

Eur Urol. 2019 Apr;75(4):667-675. doi: 10.1016/j.eururo.2018.12.042. Epub 2019 Jan 10.

PMID:
30638634
12.

Comparing diagnostic accuracy of luminal water imaging with diffusion-weighted and dynamic contrast-enhanced MRI in prostate cancer: A quantitative MRI study.

Sabouri S, Chang SD, Goldenberg SL, Savdie R, Jones EC, Black PC, Fazli L, Kozlowski P.

NMR Biomed. 2019 Feb;32(2):e4048. doi: 10.1002/nbm.4048. Epub 2018 Dec 21.

PMID:
30575145
13.

Urothelial Carcinoma in Bladder Diverticula: A Multicenter Analysis of Characteristics and Clinical Outcomes.

Voskuilen CS, Seiler R, Rink M, Poyet C, Noon AP, Roghmann F, Necchi A, Aziz A, Lavollé A, Young MJ, Marks P, Saba K, van Rhijn BWG, Fransen van de Putte EE, Ablat J, Black PC, Sosnowski R, Dobruch J, Kumar P, Jallad S, Catto JWF, Xylinas E, Hendricksen K; Young Academic Urologists’ Working Group on Urothelial Carcinoma of the European Association of Urology.

Eur Urol Focus. 2018 Dec 14. pii: S2405-4569(18)30382-1. doi: 10.1016/j.euf.2018.12.002. [Epub ahead of print]

PMID:
30559065
14.

Molecular tumor heterogeneity in muscle invasive bladder cancer: Biomarkers, subtypes, and implications for therapy.

da Costa JB, Gibb EA, Nykopp TK, Mannas M, Wyatt AW, Black PC.

Urol Oncol. 2018 Dec 8. pii: S1078-1439(18)30463-0. doi: 10.1016/j.urolonc.2018.11.015. [Epub ahead of print] Review.

PMID:
30528886
15.

Conservative management of hostile bladders with intravesical botulinum toxin for successful renal transplantation.

Niu S, Black P, Padmanabhan P.

Urol Case Rep. 2018 Oct 25;22:73-75. doi: 10.1016/j.eucr.2018.10.017. eCollection 2019 Jan. No abstract available.

16.

Immune regulation and anti-cancer activity by lipid inflammatory mediators.

Khadge S, Sharp JG, McGuire TR, Thiele GM, Black P, DiRusso C, Cook L, Klassen LW, Talmadge JE.

Int Immunopharmacol. 2018 Dec;65:580-592. doi: 10.1016/j.intimp.2018.10.026. Epub 2018 Nov 14. Review.

PMID:
30447537
17.

Immunology, Immunotherapy, and Translating Basic Science into the Clinic for Bladder Cancer.

Ingersoll MA, Li X, Inman BA, Greiner JW, Black PC, Adam RM.

Bladder Cancer. 2018 Oct 29;4(4):429-440. doi: 10.3233/BLC-180175.

18.

Experimental studies on zeta potential of flocculants for harvesting of algae.

Pandey A, Pathak VV, Kothari R, Black PN, Tyagi VV.

J Environ Manage. 2019 Feb 1;231:562-569. doi: 10.1016/j.jenvman.2018.09.096. Epub 2018 Oct 30.

PMID:
30388653
19.

Current Clinical Trials in Non-muscle Invasive Bladder Cancer.

Nykopp TK, Batista da Costa J, Mannas M, Black PC.

Curr Urol Rep. 2018 Oct 24;19(12):101. doi: 10.1007/s11934-018-0852-6. Review.

PMID:
30357541
20.

An investigation of clinical treatment field delivery verification using cherenkov imaging: IMRT positioning shifts and field matching.

Black PJ, Velten C, Wang YF, Na YH, Wuu CS.

Med Phys. 2019 Jan;46(1):302-317. doi: 10.1002/mp.13250. Epub 2018 Nov 19.

PMID:
30346639
21.

Systematic Review of Comorbidity and Competing-risks Assessments for Bladder Cancer Patients.

Williams SB, Kamat AM, Chamie K, Froehner M, Wirth MP, Wiklund PN, Black PC, Steinberg GD, Boorjian SA, Daneshmand S, Goebell PJ, Pohar KS, Shariat SF, Thalmann GN.

Eur Urol Oncol. 2018 Jun;1(2):91-100. doi: 10.1016/j.euo.2018.03.005. Epub 2018 Jun 6.

PMID:
30345422
22.

Post-translational modifications in bladder cancer: Expanding the tumor target repertoire.

Oo HZ, Seiler R, Black PC, Daugaard M.

Urol Oncol. 2018 Oct 17. pii: S1078-1439(18)30339-9. doi: 10.1016/j.urolonc.2018.09.001. [Epub ahead of print] Review.

PMID:
30342880
23.

Automatic grading of prostate cancer in digitized histopathology images: Learning from multiple experts.

Nir G, Hor S, Karimi D, Fazli L, Skinnider BF, Tavassoli P, Turbin D, Villamil CF, Wang G, Wilson RS, Iczkowski KA, Lucia MS, Black PC, Abolmaesumi P, Goldenberg SL, Salcudean SE.

Med Image Anal. 2018 Dec;50:167-180. doi: 10.1016/j.media.2018.09.005. Epub 2018 Sep 24.

PMID:
30340027
24.

Long-chain omega-3 polyunsaturated fatty acids decrease mammary tumor growth, multiorgan metastasis and enhance survival.

Khadge S, Thiele GM, Sharp JG, McGuire TR, Klassen LW, Black PN, DiRusso CC, Cook L, Talmadge JE.

Clin Exp Metastasis. 2018 Dec;35(8):797-818. doi: 10.1007/s10585-018-9941-7. Epub 2018 Oct 16.

PMID:
30327985
25.

A novel model to correlate hydrogel spacer placement, perirectal space creation, and rectum dosimetry in prostate stereotactic body radiotherapy.

Hwang ME, Black PJ, Elliston CD, Wolthuis BA, Smith DR, Wu CC, Wenske S, Deutsch I.

Radiat Oncol. 2018 Oct 1;13(1):192. doi: 10.1186/s13014-018-1135-6.

26.

Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018.

Cumberbatch MGK, Jubber I, Black PC, Esperto F, Figueroa JD, Kamat AM, Kiemeney L, Lotan Y, Pang K, Silverman DT, Znaor A, Catto JWF.

Eur Urol. 2018 Dec;74(6):784-795. doi: 10.1016/j.eururo.2018.09.001. Epub 2018 Sep 26. Review.

PMID:
30268659
27.

Selective Inhibition of the Lactate Transporter MCT4 Reduces Growth of Invasive Bladder Cancer.

Todenhöfer T, Seiler R, Stewart C, Moskalev I, Gao J, Ladhar S, Kamjabi A, Al Nakouzi N, Hayashi T, Choi S, Wang Y, Frees S, Daugaard M, Oo HZ, Fisel P, Schwab M, Schaeffeler E, Douglas J, Hennenlotter J, Bedke J, Gibb EA, Fazli L, Stenzl A, Black PC.

Mol Cancer Ther. 2018 Dec;17(12):2746-2755. doi: 10.1158/1535-7163.MCT-18-0107. Epub 2018 Sep 27.

PMID:
30262589
28.

Critical Questions To Optimize Intravesical Therapy for Non-muscle-invasive Bladder Cancer.

Black P.

Eur Urol Focus. 2018 Jul;4(4):463. doi: 10.1016/j.euf.2018.09.004. Epub 2018 Sep 24. No abstract available.

PMID:
30262197
29.

Induction of oil accumulation by heat stress is metabolically distinct from N stress in the green microalgae Coccomyxa subellipsoidea C169.

Allen JW, Tevatia R, Demirel Y, DiRusso CC, Black PN.

PLoS One. 2018 Sep 27;13(9):e0204505. doi: 10.1371/journal.pone.0204505. eCollection 2018.

30.

Immune system trickery and deception: Allograft-derived neuroendocrine carcinoma post kidney transplantation.

Chehroudi C, Mannas M, Jones EC, Nguan C, Oja C, Black PC.

Urol Case Rep. 2018 Sep 14;21:89-91. doi: 10.1016/j.eucr.2018.09.007. eCollection 2018 Nov. No abstract available.

31.

Divergent Biological Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer.

Seiler R, Gibb EA, Wang NQ, Oo HZ, Lam HM, van Kessel KE, Voskuilen CS, Winters B, Erho N, Takhar MM, Douglas J, Vakar-Lopez F, Crabb SJ, van Rhijn BWG, Fransen van de Putte EE, Zwarthoff EC, Thalmann GN, Davicioni E, Boormans JL, Dall'Era M, van der Heijden MS, Wright JL, Black PC.

Clin Cancer Res. 2018 Sep 17. doi: 10.1158/1078-0432.CCR-18-1106. [Epub ahead of print]

PMID:
30224344
32.

Systematic Review on the Utilization of Maintenance Intravesical Chemotherapy in the Management of Non-muscle-invasive Bladder Cancer.

Tabayoyong WB, Kamat AM, O'Donnell MA, McKiernan JM, Ray-Zack MD, Palou J, Brausi M, Black PC, Williams SB.

Eur Urol Focus. 2018 Jul;4(4):512-521. doi: 10.1016/j.euf.2018.08.019. Epub 2018 Sep 3. Review.

PMID:
30190111
33.

Enhancing the quality of life for stoma patients with appropriate accessory use.

Black P.

Br J Nurs. 2018 Sep 6;27(16):S14. doi: 10.12968/bjon.2018.27.16.S14. No abstract available.

PMID:
30187796
34.

Linking animal diseases and social instability.

Lubroth J, El Idrissi AH, Myers L, Hasibra M, Black P, Burgeon D.

Rev Sci Tech. 2017 Aug;36(2):445-457. doi: 10.20506/rst.36.2.2665.

PMID:
30152472
35.

A risk-stratified approach to the management of high-grade T1 bladder cancer.

Mannas MP, Lee T, Nykopp TK, Costa JBD, Black PC.

Curr Opin Urol. 2018 Nov;28(6):563-569. doi: 10.1097/MOU.0000000000000548.

PMID:
30148753
36.

Natural history of prostatic lesions on serial multiparametric magnetic resonance imaging.

Ghavimi S, Abdi H, Waterhouse J, Savdie R, Chang S, Harris A, Machan L, Gleave M, So AI, Goldenberg L, Black PC.

Can Urol Assoc J. 2018 Aug;12(8):270-275. doi: 10.4859/cuaj.4859. Epub 2018 Apr 6.

37.

New Horizons in Bladder Cancer Research: Report of the 15th Meeting of the International Bladder Cancer Network (IBCN) in Lisbon, Portugal, October 21-23, 2017.

Black PC, Goebell PJ, Kamat AM, Nawroth R, Schmitz-Dräger BJ.

Bladder Cancer. 2018 Jul 30;4(3):339-342. doi: 10.3233/BLC-189032. No abstract available.

38.

Has the Age of Cytoreductive Nephrectomy Come to an End?: Commentary on: Sunitinib Alone or After Nephrectomy in Metastatic Renal-Cell Carcinoma.

Kesch C, Black PC.

Urology. 2018 Nov;121:1-2. doi: 10.1016/j.urology.2018.07.007. Epub 2018 Aug 2. No abstract available.

PMID:
30077538
39.

Innovations in improving lipid production: Algal chemical genetics.

Wase N, Black P, DiRusso C.

Prog Lipid Res. 2018 Jul;71:101-123. doi: 10.1016/j.plipres.2018.07.001. Epub 2018 Jul 12. Review.

PMID:
30017715
40.

Real-Time FEM-Based Registration of 3-D to 2.5-D Transrectal Ultrasound Images.

Samei G, Goksel O, Lobo J, Mohareri O, Black P, Rohling R, Salcudean S.

IEEE Trans Med Imaging. 2018 Aug;37(8):1877-1886. doi: 10.1109/TMI.2018.2810778. Epub 2018 Feb 28.

PMID:
29994583
41.

Dosimetric verification and commissioning for a small animal image-guided irradiator.

Wang YF, Lin SC, Na YH, Black PJ, Wuu CS.

Phys Med Biol. 2018 Jul 9;63(14):145001. doi: 10.1088/1361-6560/aacdcd.

PMID:
29923495
42.

The Oncolytic Adenovirus XVir-N-31 as a Novel Therapy in Muscle-Invasive Bladder Cancer.

Lichtenegger E, Koll F, Haas H, Mantwill K, Janssen KP, Laschinger M, Gschwend J, Steiger K, Black PC, Moskalev I, Nawroth R, Holm PS.

Hum Gene Ther. 2019 Jan;30(1):44-56. doi: 10.1089/hum.2018.026. Epub 2018 Aug 3.

PMID:
29916265
43.

Outcomes of Magnetic Resonance Imaging-Ultrasound Fusion Prostate Biopsy of PI-RADS 3, 4, and 5 Lesions.

Gosein M, Pang E, Chang S, Black P, Goldenberg L, Harris A, Yasenjiang J, Yousefi M.

Can Assoc Radiol J. 2018 Aug;69(3):303-310. doi: 10.1016/j.carj.2018.03.001. Epub 2018 Jun 9. No abstract available.

PMID:
29895436
44.

Velocity-based Adaptive Registration and Fusion for Fractionated Stereotactic Radiosurgery Using the Small Animal Radiation Research Platform.

Black PJ, Smith DR, Chaudhary K, Xanthopoulos EP, Chin C, Spina CS, Hwang ME, Mayeda M, Wang YF, Connolly EP, Wang TJC, Wuu CS, Hei TK, Cheng SK, Wu CC.

Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):841-847. doi: 10.1016/j.ijrobp.2018.04.067. Epub 2018 May 4.

PMID:
29891199
45.

Azithromycin for Early Pseudomonas Infection in Cystic Fibrosis. The OPTIMIZE Randomized Trial.

Mayer-Hamblett N, Retsch-Bogart G, Kloster M, Accurso F, Rosenfeld M, Albers G, Black P, Brown P, Cairns A, Davis SD, Graff GR, Kerby GS, Orenstein D, Buckingham R, Ramsey BW; OPTIMIZE Study Group.

Am J Respir Crit Care Med. 2018 Nov 1;198(9):1177-1187. doi: 10.1164/rccm.201802-0215OC. Erratum in: Am J Respir Crit Care Med. 2019 Mar 15;199(6):809.

PMID:
29890086
46.

Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy.

Vasdev N, Zargar H, Noël JP, Veeratterapillay R, Fairey AS, Mertens LS, Dinney CP, Mir MC, Krabbe LM, Cookson MS, Jacobsen NE, Gandhi NM, Griffin J, Montgomery JS, Yu EY, Xylinas E, Campain NJ, Kassouf W, Dall'Era MA, Seah JA, Ercole CE, Horenblas S, Sridhar SS, McGrath JS, Aning J, Shariat SF, Wright JL, Morgan TM, Bivalacqua TJ, North S, Barocas DA, Lotan Y, Grivas P, Stephenson AJ, Shah JB, van Rhijn BW, Daneshmand S, Spiess PE, Holzbeierlein JM, Thorpe A, Black PC.

World J Urol. 2019 Jan;37(1):165-172. doi: 10.1007/s00345-018-2361-0. Epub 2018 Jun 7.

PMID:
29882105
47.

Isolation and genome sequencing of individual circulating tumor cells using hydrogel encapsulation and laser capture microdissection.

Park ES, Yan JP, Ang RA, Lee JH, Deng X, Duffy SP, Beja K, Annala M, Black PC, Chi KN, Wyatt AW, Ma H.

Lab Chip. 2018 Jun 12;18(12):1736-1749. doi: 10.1039/c8lc00184g.

PMID:
29762619
48.

Dosimetric and geometric characteristics of a small animal image-guided irradiator using 3D dosimetry/optical CT scanner.

Na YH, Wang YF, Black PJ, Velten C, Qian X, Lin SC, Adamovics J, Wuu CS.

Med Phys. 2018 Jul;45(7):3330-3339. doi: 10.1002/mp.12955. Epub 2018 Jun 3.

PMID:
29746014
49.

Magnet Before the Needle Commentary on: MRI-targeted or Standard Biopsy for Prostate-cancer Diagnosis (PRECISION Trial).

Merrett C, Mannas M, Black PC, Zargar H.

Urology. 2018 Aug;118:1-2. doi: 10.1016/j.urology.2018.04.024. Epub 2018 May 3. No abstract available.

PMID:
29730255
50.

Students views of an online ethical decision-support tool.

Allinson MD, Black P.

Curr Pharm Teach Learn. 2018 Feb;10(2):226-230. doi: 10.1016/j.cptl.2017.10.008. Epub 2017 Oct 19.

PMID:
29706280

Supplemental Content

Support Center